Dare Bioscience, Inc.

San Diego, CA

UEI
UC4EFLZHANH4
CAGE
5UT09
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3655 Nobel Dr UNIT 260, San Diego, CA 92122, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
Trustees Of Boston University Scope of Work Dare Bioscience efforts for Boston University (Deborah Anderson PhD) “Antibody-based Contraceptive MPTs: Advancing the Human Contraceptive… P50HD096957 $104,048

Similar vendors

About the company

Dare Bioscience, Inc. is a corporate entity registered in San Diego, California, specializing in developing innovative women's healthcare technologies and pharmaceutical solutions. As a self-certified small disadvantaged business, the company focuses on creating advanced medical products targeting reproductive health, contraception, and infectious disease prevention. The organization is registered in SAM.gov through September 2025 and has successfully secured multiple federal grant awards, primarily from national health institutes to support research and development of cutting-edge medical technologies.

The company has received federal grant awards from agencies like the National Institute of Child Health and Human Development and the National Institute of Allergy and Infectious Diseases, focusing on developing sophisticated medical interventions. These grants have supported projects such as a long-acting injectable hormonal contraceptive, an intravaginal ring for preventing preterm birth, a user-controlled long-acting reversible contraceptive device, and an innovative anti-viral vaginal insert for clearing high-risk human papillomavirus infections. Dare Bioscience has also engaged in sub-grant work, such as collaborating with Boston University on a contraceptive antibody development project. Their grant-funded research demonstrates a strong commitment to advancing women's reproductive health technologies through rigorous scientific research, with a particular emphasis on creating more effective, user-friendly contraceptive and therapeutic solutions that address significant medical challenges.

Quick answers

Is Dare Bioscience, Inc. registered in SAM.gov?

Yes. Dare Bioscience, Inc.'s SAM.gov registration is active through July 8, 2027.

What is Dare Bioscience, Inc.'s CAGE code?

Dare Bioscience, Inc.'s CAGE code is 5UT09, and its Unique Entity ID (UEI) is UC4EFLZHANH4.

What is Dare Bioscience, Inc.'s most recent federal award?

Dare Bioscience, Inc.'s most recent federal grant award is A first-in-class product for the clearance of high-risk human papillomaviruses (R44AI188623), from National Institute of Allergy and Infectious Diseases (NIH), on December 17, 2024.

On GovTribe

See Dare Bioscience, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe